The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

And the paperwork, sometimes called the medication guide or patient package insert, may contain details about interactions. If Ozempic does not come with paperwork, you can ask your pharmacist to ...

By Dani Blum The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have both Type 2 diabetes and chronic kidney disease.